Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Bora Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Bora Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $741.35. The average 1-year stock price forecast is 99.56% higher than the current stock price, while the lowest is $530.00 (+42.66%) and the highest is $1,060 (+185.33%).

Price Target: $741.35 (+99.56%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$530.00	$741.35	$690.65	$1,060
Change	+42.66%	+99.56%	+85.91%	+185.33%

Analyst Ratings

The average analyst rating for Bora Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	1	1	1
Buy	4	4	4	4	4	4
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Financial Forecast

Revenue This Year

23.69B

Increased by 24.61%

from 19.01B

Revenue Next Year

32.43B

Increased by 36.88%

from 23.69B

EPS This Year

32.11

Increased by 103.13%

from 15.81

EPS Next Year

57.23

Increased by 78.25%

from 32.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.90B	10.49B	14.20B	17.43B	19.01B	23.69B
Revenue Growth	172.28%	114.18%	35.31%	22.72%	9.11%	24.61%
Gross Profit	1.67B	2.91B	6.99B	7.79B	7.85B	9.78B
Gross Margin	34.12%	27.76%	49.23%	44.70%	41.30%	41.27%
Operating Income	1.05B	1.92B	5.25B	3.71B	3.29B	5.48B
Net Income	749.74M	1.39B	3.03B	3.85B	2.98B	3.90B
Dividend / Share	2.04	5.13	10.00	14.00	10.00	13.06
Dividend Growth	-	151.53%	94.84%	39.98%	-28.57%	30.57%
Free Cash Flow	625.48M	1.04B	3.15B	-4.58B	2.90B	-6.64B
No. Analysts	-	-	-	-	-	6

Financial currency is TWD.

Revenue Forecast

Revenue	2026	2027
High	28.8B
Avg	23.7B
Low	19.9B

Revenue Growth

Revenue Growth	2026	2027
High	51.7%
Avg	24.6%
Low	4.7%

EPS Forecast

EPS	2026	2027
High	49.54
Avg	32.11
Low	20.55

EPS Growth

EPS Growth	2026	2027
High	213.4%
Avg	103.1%
Low	30.0%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.